4.7 Article

Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

The unexpected benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors

Chok G. Chan et al.

Summary: The SGLT2 inhibitor empagliflozin is funded for the treatment of type 2 diabetes patients in New Zealand with a high cardiovascular risk. Recent clinical trials show strong evidence that SGLT2 inhibitors can reduce the risk of cardiovascular death, heart failure, kidney dysfunction, myocardial infarction, stroke, and gout. This suggests that expanding funding to include patients with heart failure or kidney dysfunction without diabetes would benefit more people in New Zealand.

NEW ZEALAND MEDICAL JOURNAL (2022)

Article Medicine, General & Internal

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

V. Perkovic et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients

Munemitsu Otagaki et al.

CARDIOVASCULAR DRUGS AND THERAPY (2019)

Meeting Abstract Cardiac & Cardiovascular Systems

SGLT-2 Inhibition Does Not Improve Left Ventricular Reverse Remodeling in Patients with Diabetes Mellitus Type 2

Swathi Roy et al.

JOURNAL OF CARDIAC FAILURE (2019)

Article Medicine, General & Internal

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

J. J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

S. D. Wiviott et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Cardiac & Cardiovascular Systems

Utility of strain imaging in conjunction with heart failure stage classification for heart failure patient management

Hidekazu Tanaka

JOURNAL OF ECHOCARDIOGRAPHY (2019)

Editorial Material Cardiac & Cardiovascular Systems

Body mass index, type 2 diabetes, and left ventricular function

Katrine Dina Musaeus et al.

CARDIOVASCULAR DIABETOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitus

Hidekazu Tanaka et al.

HEART FAILURE REVIEWS (2018)

Article Cardiac & Cardiovascular Systems

Impact of left ventricular longitudinal functional mechanics on the progression of diastolic function in diabetes mellitus

Yasuhide Mochizuki et al.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2017)

Article Cardiac & Cardiovascular Systems

Estimating Left Ventricular Filling Pressure by Echocardiography

Oyvind S. Andersen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Medicine, General & Internal

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Bruce Neal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus

Melissa Leung et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2016)

Review Cardiac & Cardiovascular Systems

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski et al.

EUROPEAN HEART JOURNAL (2016)

Article Cardiac & Cardiovascular Systems

Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction

Yasuhide Mochizuki et al.

CARDIOVASCULAR DIABETOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus

Yasuhide Mochizuki et al.

CARDIOVASCULAR DIABETOLOGY (2015)

Article Medicine, General & Internal

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Cardiac & Cardiovascular Systems

Longitudinal Myocardial Strain Alteration Is Associated with Left Ventricular Remodeling in Asymptomatic Patients with Type 2 Diabetes Mellitus

Laura Ernande et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)

Article Endocrinology & Metabolism

Association of diabetes mellitus with myocardial collagen accumulation and relaxation impairment in patients with dilated cardiomyopathy

Masaki Sakakibara et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2011)

Review Cardiac & Cardiovascular Systems

Echocardiographic Assessment of Myocardial Strain

John Gorcsan et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus: Is It Really the First Marker of Diabetic Cardiomyopathy?

Laura Ernande et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2011)

Article Cardiac & Cardiovascular Systems

Global Longitudinal Strain as a Major Predictor of Cardiac Events in Patients with Depressed Left Ventricular Function: A Multicenter Study

Aude Mignot et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2010)

Article Cardiac & Cardiovascular Systems

Impaired Myocardial Radial Function in Asymptomatic Patients with Type 2 Diabetes Mellitus: A Speckle-Tracking Imaging Study

Laura Ernande et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2010)

Article Cardiac & Cardiovascular Systems

Findings from Left Ventricular Strain and Strain Rate Imaging in Asymptomatic Patients With Type 2 Diabetes Mellitus

Arnold C. T. Ng et al.

AMERICAN JOURNAL OF CARDIOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain Comparison With Ejection Fraction and Wall Motion Scoring

Tony Stanton et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2009)